tiprankstipranks
Advertisement
Advertisement

ARTV Stock Latest News

Artiva Biotherapeutics Sets Deadline for 2026 Meeting
Company AnnouncementsArtiva Biotherapeutics Sets Deadline for 2026 Meeting
10d ago
8K
ARTV
Fourteen new option listings and one option delisting on July 22nd
PremiumThe Fly
Fourteen new option listings and one option delisting on July 22nd
10d ago
ACOG
ARTV
Artiva Biotherapeutics highlights AlloNK data presented at EULAR 2026
PremiumThe Fly
Artiva Biotherapeutics highlights AlloNK data presented at EULAR 2026
2M ago
ARTV
Artiva Biotherapeutics Announces Major Executive Leadership Transitions
PremiumCompany Announcements
Artiva Biotherapeutics Announces Major Executive Leadership Transitions
2M ago
8K
ARTV
Artiva Biotherapeutics price target raised to $41 from $18 at Needham
PremiumThe Fly
Artiva Biotherapeutics price target raised to $41 from $18 at Needham
3M ago
ARTV
Artiva Biotherapeutics price target raised to $40 from $23 at Wedbush
PremiumThe FlyArtiva Biotherapeutics price target raised to $40 from $23 at Wedbush
3M ago
ARTV
Tyler Van Buren Reiterates Buy on Artiva, Citing Strong AlloNK RA Efficacy and Funded Path to Registrational Trial
Premium
Ratings
Tyler Van Buren Reiterates Buy on Artiva, Citing Strong AlloNK RA Efficacy and Funded Path to Registrational Trial
3M ago
ARTV
Artiva Biotherapeutics Announces $300 Million Equity Offering
Premium
Company Announcements
Artiva Biotherapeutics Announces $300 Million Equity Offering
3M ago
8K
ARTV
Artiva Biotherapeutics price target raised to $35 from $15 at H.C. Wainwright
PremiumThe Fly
Artiva Biotherapeutics price target raised to $35 from $15 at H.C. Wainwright
3M ago
ARTV
Artiva Highlights AlloNK RA Data and Phase 3 Alignment
PremiumCompany Announcements
Artiva Highlights AlloNK RA Data and Phase 3 Alignment
3M ago
8K
ARTV
Artiva Biotherapeutics reports Q1 EPS (95c), consensus (84c)
PremiumThe Fly
Artiva Biotherapeutics reports Q1 EPS (95c), consensus (84c)
3M ago
ARTV
Artiva reports data from clinical trials evaluating AlloNK
PremiumThe Fly
Artiva reports data from clinical trials evaluating AlloNK
3M ago
ARTV
Artiva: Sufficient Cash Runway to 2027 Supports Buy Rating Ahead of Key 2026 RA Efficacy Readouts
PremiumRatingsArtiva: Sufficient Cash Runway to 2027 Supports Buy Rating Ahead of Key 2026 RA Efficacy Readouts
5M ago
ARTV
Artiva: De-Risking RA Opportunity With AlloNK and Fast-Track Path Supports Buy Rating
Premium
Ratings
Artiva: De-Risking RA Opportunity With AlloNK and Fast-Track Path Supports Buy Rating
5M ago
ARTV
Artiva Biotherapeutics Appoints Thad Huston as Chief Financial Officer
Premium
Company Announcements
Artiva Biotherapeutics Appoints Thad Huston as Chief Financial Officer
5M ago
8K
ARTV
Artiva Biotherapeutics appoints Huston as Chief Financial Officer
PremiumThe Fly
Artiva Biotherapeutics appoints Huston as Chief Financial Officer
5M ago
ARTV
Artiva Biotherapeutics Adds Veteran Executive Elaine Sorg to Board
PremiumCompany Announcements
Artiva Biotherapeutics Adds Veteran Executive Elaine Sorg to Board
5M ago
8K
ARTV
Artiva Biotherapeutics appoints Sorg to board of directors
PremiumThe Fly
Artiva Biotherapeutics appoints Sorg to board of directors
5M ago
ARTV
Artiva (ARTV): Off‑the‑Shelf AlloNK Platform Positions Lead RA Program for Pivotal De‑Risking and Attractive Risk‑Reward
PremiumRatings
Artiva (ARTV): Off‑the‑Shelf AlloNK Platform Positions Lead RA Program for Pivotal De‑Risking and Attractive Risk‑Reward
5M ago
ARTV
Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & IdeasWedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks
8M ago
ARTV
BCRX
Artiva Biotherapeutics Executes RSU Exchange for Employees
Premium
Company Announcements
Artiva Biotherapeutics Executes RSU Exchange for Employees
8M ago
8K
ARTV
Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development
Premium
Company Announcements
Artiva Biotherapeutics Reports Increased Losses Amid Ongoing Development
9M ago
ARTV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >